MELISSA PEYTON: Open Payments
NPI 1679315295 · VACAVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $53 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $97 |
| Lilly USA, LLC | 5 | $78 |
| PFIZER INC. | 3 | $49 |
| Exact Sciences Corporation | 3 | $47 |
| Astellas Pharma US Inc | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Mannkind Corporation | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: MOUNJARO, Ozempic, NURTEC ODT, Cologuard Collection Kit, Veozah, JARDIANCE, VOQUEZNA, AFREZZA.
Industry payments across CA — which companies pay providers there.
